[1]
Güzelbulut, F. et al. 2021. Comparison of the Efficacy of Entecavir and Tenofovir in Reducing Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients: A Real-Life Study in Turkey. Turkish Journal of Gastroenterology. 32, 4 (Jan. 2021), 412–421. DOI:https://doi.org/10.5152/tjg.2021.20423.